Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

(How) do aluminium adjuvants work?

James M Brewer1

  • 1Division of Immunology, Infection and Inflammation, University of Glasgow, Western Infirmary, Glasgow G11 6NT, UK. j.m.brewer@clinmed.gla.ac.uk

Immunology Letters
|September 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spermidine suppresses DC activation via eIF5A hypusination and metabolic adaptation.

Discovery immunology·2025
Same author

Revealing stromal and lymphoid sources of <i>Col3a1</i>-expression during inflammation using a novel reporter mouse.

Discovery immunology·2024
Same author

Review: Unravelling the Role of DNA Sensing in Alum Adjuvant Activity.

Discovery immunology·2024
Same author

The effect of abatacept on T-cell activation is not long-lived <i>in vivo</i>.

Discovery immunology·2024
Same author

Orally administered antigen can reduce or exacerbate pathology in an animal model of inflammatory arthritis dependent upon the timing of administration.

Immunotherapy advances·2022
Same author

Streptococcus pneumoniae Rapidly Translocate from the Nasopharynx through the Cribriform Plate to Invade the Outer Meninges.

mBio·2022

Aluminium adjuvants in vaccines are widely used but poorly understood. This review explores their physicochemical properties and biological mechanisms to improve vaccine efficacy and reduce failures.

Area of Science:

  • Vaccinology
  • Immunology
  • Materials Science

Background:

  • Aluminium compounds have been used as vaccine adjuvants for over 70 years.
  • The physicochemical interactions between aluminium adjuvants and antigens are not well understood.
  • The mechanisms of action for aluminium adjuvants are largely unstudied.

Purpose of the Study:

  • To review recent developments in understanding aluminium adjuvants.
  • To examine the physicochemical properties of aluminium adjuvants.
  • To explore the biological mechanisms of aluminium adjuvants.

Main Methods:

  • Literature review of physicochemical and biological aspects of aluminium adjuvants.
  • Analysis of existing research on aluminium adjuvant interactions with antigens.

Related Experiment Videos

  • Examination of studies on the immune response activation by aluminium adjuvants.

    • Main Results:

    • Physicochemical interactions between aluminium compounds and antigens are poorly understood, contributing to vaccine failures.
    • The mechanisms of action of aluminium adjuvants do not align with current principles of immune response activation.
    • Recent research has shed light on the complex nature of aluminium adjuvants.

    Conclusions:

    • A deeper understanding of aluminium adjuvants is crucial for improving vaccine design and efficacy.
    • Further research into the physicochemical and biological aspects of aluminium adjuvants is warranted.
    • Addressing the knowledge gaps in aluminium adjuvant function can help prevent vaccine failures.